IMMUNOGLOBULIN G4 RELATED DISEASE
Clinical trials for IMMUNOGLOBULIN G4 RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGLOBULIN G4 RELATED DISEASE trials appear
Sign up with your email to follow new studies for IMMUNOGLOBULIN G4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
A steroid-sparing strategy for IgG4-related disease: lenalidomide put to the test
Disease control Not yet recruitingThis phase III trial tests whether lenalidomide, an immune-modulating drug, can prevent disease flares in people with IgG4-related disease who are in remission. Participants receive either lenalidomide or a placebo for 52 weeks while tapering off steroids. The goal is to see if l…
Matched conditions: IMMUNOGLOBULIN G4 RELATED DISEASE
Phase: PHASE3 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug trial aims to tame rare inflammatory disease in kids
Disease control Not yet recruitingThis study tests a drug called inebilizumab in 15 children aged 2 to 17 who have IgG4-related disease, a rare condition that causes swelling and damage in organs. The drug is given through an IV and works by lowering certain immune cells to reduce inflammation. Researchers will c…
Matched conditions: IMMUNOGLOBULIN G4 RELATED DISEASE
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC